RSS Feed
July 4th, 2023 
Awake Goy Now that the pandemic has ended, researchers are urging regulatory agencies to consider the safety issues associated with the rapid approval of COVID-19 vaccines—and to correctly classify messenger RNA (mRNA) vaccines as gene therapy products (GTPs) to prevent pharmaceutical companies from bypassing regulatory standards.
Related posts:
Second nuclear missile test launched by Navy as U.S. Defense Secretary confirms warning message to A...
Research “Game-changer”: Jabs Increase Heart Attacks, Destroy Immune Systems
WATCH! Proof that the Covid vax and alcohol do not mix well.
Fauci Denies Excluding Redfield from COVID Origins Call, Doesn't Denounce His Exclusion
Want To Raise Kind Kids? Harvard Says These 5 Techniques Will Help You Do That
How One Midrasha Is Solving The COVID-19 Challenge
Posted in 
Tags: 
